[1]
K. Y. Ibrahim, “Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons”, Rev. Inst. Med. Trop. São Paulo, vol. 66, p. e24, abr. 2024, doi: 10.1590/.